In keeping with our results, the authors of a published review concluded that circulating OPG levels could be used as an independent biomarker of cardiovascular disease in patients with acute or chronic cardio-metabolic diseases to improve the prognosis [37]. This evidence concerns the gene TNFRSF11B and cardiovascular disorder.